Last update:

Commonly used drug kills leukemia cells early by acting mainly on RNA, not DNA

For more than two decades, azacitidine has been a major treatment for blood cancers such as high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The drug was thought to work through DNA, by stripping ...

Improved mapping reveals location of small molecules in the brain

Hsi-Chun Chao, a postdoctoral researcher at the Beckman Institute for Advanced Science and Technology at the University of Illinois Urbana-Champaign, developed a new methodology to map the locations of and differentiate nearly ...

Medical research news

Can psychedelics improve decision-making?

For the one-in-five Americans with a mental health condition, the options for treatment aren't too much different from what they were half a century ago. Most medicines for psychiatric disorders were first pioneered in the ...

Immune aging blueprint offers new clues to fighting cancer

A new study from Monash University has uncovered a genetic blueprint of immune aging, shedding light on why our bodies become less effective at fighting cancer and infections as we grow older. Published in Science Immunology, ...

Why humans get the worst of Ebola virus

Illnesses from Ebola virus and its relatives have about a 50% fatality rate in humans. The current outbreak in the Democratic Republic of Congo has already caused over 10,500 confirmed cases and over 5,130 deaths, according ...